CVS Unveils Q3 Results Amid Leadership Changes at Aetna
CVS Health Corporation reported a 6.3% increase in third-quarter revenues to $95.4 billion, but saw a significant drop in GAAP diluted EPS to $0.07 from $1.75 the previous year, and adjusted EPS to $1.09 from $2.21. The decline is attributed to challenges in the Health Care Benefits segment, including $1.1 billion in premium deficiency reserves related to anticipated losses in Medicare and individual exchange product lines. These reserves are expected to be released in the fourth quarter, potentially improving future results.